(Q48647228)

13 February 2018

title

Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. (English)

1 reference

13 February 2018

0 references

0 references

Sandra Hulshof

1

1 reference

13 February 2018

Lisette Montagne

series ordinal

2

1 reference

13 February 2018

Corline J A De Groot

series ordinal

3

1 reference

13 February 2018

Paul Van Der Valk

series ordinal

4

1 reference

13 February 2018

publication date

1 April 2002

1 reference

13 February 2018

published in

Glia

1 reference

13 February 2018

volume

38

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

24-35

1 reference

13 February 2018

Biology of TGF-beta in knockout and transgenic mouse models

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Establishment of microglial cell cultures derived from postmortem human adult brain tissue: immunophenotypical and functional characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

A receptor for interleukin 10 is related to interferon receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Characterization of tumor necrosis factor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Cytokines in inflammatory brain lesions: helpful and harmful

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Exacerbations of multiple sclerosis in patients treated with gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Cytokines in Alzheimer's disease and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin-4 production and associated eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Transforming growth factor-beta1 induces apoptosis of rat microglia without relation to bcl-2 oncoprotein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

Oral or intravenous methylprednisolone for acute relapses of MS?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

IL-10 fails to abrogate experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

Tumor necrosis factor alpha but not lymphotoxin is overproduced by blood mononuclear cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

Production of interleukin-10 by mouse glial cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10050

7 January 2021

Identifiers

DOI

10.1002/GLIA.10050

1 reference

13 February 2018

1 reference

13 February 2018